Vazquez E - Search Results

1

Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer.

Leonardi DB, Anselmino N, Brandani JN, Jaworski FM, Páez AV, Mazaira G, Meiss RP, Nuñez M, Nemirovsky SI, Giudice J, Galigniana M, Pecci A, Gueron G, Vazquez E, Cotignola J. Leonardi DB, et al. Among authors: vazquez e. Int J Mol Sci. 2019 Feb 26;20(5):1006. doi: 10.3390/ijms20051006. Int J Mol Sci. 2019. PMID: 30813528 Free PMC article.

2

Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis.

Caballero F, Meiss R, Gimenez A, Batlle A, Vazquez E. Caballero F, et al. Among authors: vazquez e. Int J Exp Pathol. 2004 Oct;85(4):213-22. doi: 10.1111/j.0959-9673.2004.00391.x. Int J Exp Pathol. 2004. PMID: 15312126 Free PMC article.

3

Homeostatic response under carcinogen withdrawal, heme oxygenase 1 expression and cell cycle association.

Castronuovo CC, Sacca PA, Meiss R, Caballero FA, Batlle A, Vazquez ES. Castronuovo CC, et al. BMC Cancer. 2006 Dec 14;6:286. doi: 10.1186/1471-2407-6-286. BMC Cancer. 2006. PMID: 17169158 Free PMC article.

4

Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer.

Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N, Vazquez E. Sacca P, et al. Among authors: vazquez e. Br J Cancer. 2007 Dec 17;97(12):1683-9. doi: 10.1038/sj.bjc.6604081. Epub 2007 Nov 20. Br J Cancer. 2007. PMID: 18026199 Free PMC article.

5

Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.

Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, Vazquez ES. Gueron G, et al. Mol Cancer Res. 2009 Nov;7(11):1745-55. doi: 10.1158/1541-7786.MCR-08-0325. Epub 2009 Nov 10. Mol Cancer Res. 2009. PMID: 19903769

6

Key questions in metastasis: new insights in molecular pathways and therapeutic implications.

Gueron G, De Siervi A, Vazquez E. Gueron G, et al. Among authors: vazquez e. Curr Pharm Biotechnol. 2011 Nov;12(11):1867-80. doi: 10.2174/138920111798376996. Curr Pharm Biotechnol. 2011. PMID: 21470130 Review.

7

BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

De Luca P, Vazquez ES, Moiola CP, Zalazar F, Cotignola J, Gueron G, Gardner K, De Siervi A. De Luca P, et al. Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23. Mol Cancer Res. 2011. PMID: 21700680 Free PMC article.

8

Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer.

Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, Leskow FC, Jares-Erijman EA, Colombo L, Meiss R, Navone N, De Siervi A, Vazquez E. Ferrando M, et al. Among authors: vazquez e. Angiogenesis. 2011 Dec;14(4):467-79. doi: 10.1007/s10456-011-9230-4. Epub 2011 Aug 11. Angiogenesis. 2011. PMID: 21833623

9

Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.

Gueron G, De Siervi A, Vazquez E. Gueron G, et al. Among authors: vazquez e. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):213-21. doi: 10.1038/pcan.2011.64. Epub 2011 Dec 20. Prostate Cancer Prostatic Dis. 2012. PMID: 22183772 Review.

10

Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription.

Moiola C, De Luca P, Cotignola J, Gardner K, Vazquez E, De Siervi A. Moiola C, et al. Among authors: vazquez e. Cell Physiol Biochem. 2012;30(3):596-608. doi: 10.1159/000341441. Epub 2012 Jul 27. Cell Physiol Biochem. 2012. PMID: 22832221 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,054 results

Search Page

Filters